In 2024, the U.S. Drug Enforcement Administration (DEA) indicated that they intend to reclassify marijuana as a Agenda III drug. This rescheduling will recognize that cannabis has legitimate health-related needs and might help open the doorway to analysis on other possible procedure makes use of